These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 517252)

  • 21. Essential role of kallikrein-kinin system in suppression of blood pressure rise during the developmental stage of hypertension induced by deoxycorticosterone acetate-salt in rats.
    Katori M; Majima M; Mohsin SS; Hanazuka M; Mizogami S; Oh-ishi S
    Agents Actions Suppl; 1992; 38 ( Pt 3)():235-42. PubMed ID: 1281379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine and human plasma prekallikrein.
    Heimark RL; Davie EW
    Methods Enzymol; 1981; 80 Pt C():157-72. PubMed ID: 6918767
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation of inactive kallikrein from rat urine.
    Takaoka M; Akiyama H; Ito K; Okamura H; Morimoto S
    Biochem Biophys Res Commun; 1982 Dec; 109(3):841-7. PubMed ID: 6925450
    [No Abstract]   [Full Text] [Related]  

  • 24. [Isolation and determination of human plasma prekallikrein].
    Simonianová E; Rybák M; Kasafírek E; Lostický C
    Cesk Farm; 1984 Dec; 33(10):417-9. PubMed ID: 6570444
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contact-activated and immunoreactive prekallikrein in the plasma of patients with hypertension].
    Karpitskiĭ VV; Iakubovskaia RI; Paskhina TS
    Vopr Med Khim; 1987; 33(2):116-22. PubMed ID: 3111085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new prekallikrein activator in human plasma which differs from Hageman factor and its fragments.
    Webster ME; Stella RC; Villa ML; Toffoletto O
    Adv Exp Med Biol; 1979; 120B():53-9. PubMed ID: 517247
    [No Abstract]   [Full Text] [Related]  

  • 29. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
    Kaplan AP
    Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477
    [No Abstract]   [Full Text] [Related]  

  • 30. [Renal prokallikrein and its activation].
    Nishimura K; Shimizu H; Kokubu T
    Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):909-10. PubMed ID: 6559218
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation and determination of human urinary kallikrein.
    Geiger R; Fink E; Stuckstedte U; Förg-Brey B
    Adv Biosci; 1978 Jul; 17():127-32. PubMed ID: 755688
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material.
    Saito H; Goodnough LT; Soria J; Soria C; Aznar J; España F
    N Engl J Med; 1981 Oct; 305(16):910-4. PubMed ID: 6792540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of kallikrein in human pancreatic juice. Immunological and inhibition studies.
    Amouric M; Figarella C
    Adv Biosci; 1978 Jul; 17():103-10. PubMed ID: 114438
    [No Abstract]   [Full Text] [Related]  

  • 35. The location of prekallikrein in the rat pancreas [proceedings].
    Proud D; Bailey GS; Orstavik TB; Nustad K
    Biochem Soc Trans; 1977; 5(5):1402-4. PubMed ID: 411695
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of a chromatographic method for determining kallikrein and prekallikrein in dog blood serum].
    Dotsenko VL; Saiapin VN; Neshkova EA; Iarovaia GA
    Biull Eksp Biol Med; 1982 Aug; 94(8):117-20. PubMed ID: 6922725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of prekallikrein in the cases with disseminated intravascular coagulation syndrome.
    Sakuragawa N; Takahashi K; Shibata A
    Adv Exp Med Biol; 1979; 120B():185-93. PubMed ID: 160191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system.
    Lopes-Martins RA; Antunes E; Oliva ML; Sampaio CA; Burton J; de Nucci G
    Br J Pharmacol; 1994 Sep; 113(1):81-6. PubMed ID: 7529116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New aspects of the blood flow-augmenting and insulin-like activity of muscle exercise: possible involvement of the kallikrein-kinin-prostaglandin system (author's transl)].
    Dietze G
    Klin Wochenschr; 1982 May; 60(9):429-44. PubMed ID: 6806524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.